US Supreme Court rejects Novozymes appeal

Supreme Court refused to take a look at the company’s appeal in a patent case involving its competitor DuPont

The Danish biotech giant Novozymes was met with adversity on the US market on Monday after the US Supreme Court refused to take a look at the company’s appeal in a patent case involving its competitor DuPont.

The case stems from 2009 and revolves around the US authorities rejecting a Novozymes patent extension application for an enzyme variant that is used to produce bioethanol.

Then in the summer of 2013, a US court upheld the earlier decision that the application was imprecise and ruled that it did not live up to US patent standards.

DuPont had applied for a patent in 2006 that overlapped with what Novozymes was seeking to extend a patent on in connection with the production of ethanol from corn.

Initially, a jury at the US District Court awarded 18 million dollars (about 98 million kroner) in damages to Novozymes, before a senior judge overturned the decision.





  • How internationals can benefit from joining trade unions

    How internationals can benefit from joining trade unions

    Being part of a trade union is a long-established norm for Danes. But many internationals do not join unions – instead enduring workers’ rights violations. Find out how joining a union could benefit you, and how to go about it.

  • Internationals in Denmark rarely join a trade union

    Internationals in Denmark rarely join a trade union

    Internationals are overrepresented in the lowest-paid fields of agriculture, transport, cleaning, hotels and restaurants, and construction – industries that classically lack collective agreements. A new analysis from the Workers’ Union’s Business Council suggests that internationals rarely join trade unions – but if they did, it would generate better industry standards.

  • Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    The numbers are especially striking amongst the 3,477 business and economics students polled, of whom 31 percent elected Novo Nordisk as their favorite, compared with 20 percent last year.